Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,662,139
in 5 filings, $21.7M under 10b5-1 plans

Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-25 Posard Matthew L. Director Grant or award +6,501 119,755
2024-04-25 Posard Matthew L. Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 Miyashita Akiko Moni Director Grant or award +6,501 20,772
2024-04-25 Miyashita Akiko Moni Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 MATSUI CONNIE Director Grant or award +6,501 193,505
2024-04-25 MATSUI CONNIE Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 Krishnan Mahesh Director Grant or award +6,501 6,501
2024-04-25 Krishnan Mahesh Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 Henderson Jeffrey William Director Grant or award +6,501 53,611
2024-04-25 Henderson Jeffrey William Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 Duncan Barbara Gayle Director Grant or award +6,501 15,754
2024-04-25 Duncan Barbara Gayle Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-25 Connaughton Bernadette Director Grant or award +6,501 46,787
2024-04-25 Connaughton Bernadette Director Grant or award · Option to Purchase Common Stock +8,804 8,804
2024-04-17 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion 10b5-1 +10,000 $8.11 $81K 178,176
2024-04-17 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,000 $38.49 $385K 168,176
2024-04-17 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 41,715
2024-04-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion 10b5-1 +10,000 $8.11 $81K 178,176
2024-04-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,000 $38.35 $384K 168,176
2024-04-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 51,715

Page 30 of 48 · 944 trades